Literature DB >> 6814163

Onset and regression of neuroaxonal lesions in sheep with mannosidosis induced experimentally with swainsonine.

C R Huxtable, P R Dorling, S U Walkley.   

Abstract

A group of young sheep were fed a diet containing the alpha-mannosidase inhibitor swainsonine, which resulted in the induction of a neuronal lysosomal mannoside storage disease. Sheep were killed at various intervals during and following the treatment period and the nature and distribution of neuronal and axonal lesions in the brain were assessed by routine light and electron microscopy and by the rapid Golgi impregnation technique. Neuronal mannoside storage, axonal dystrophy and meganeurite formation were induced by 80 days of treatment and the lesions had regressed by 40 days after the end of treatment. The results are discussed in relation to their relevance to the current widespread interest in the pathobiology of neuronal lysosomal storage.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6814163     DOI: 10.1007/bf00692694

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  24 in total

1.  GM1 gangliosidosis in Friesian calves.

Authors:  W J Donnelly; B J Sheahan; T A Rogers
Journal:  J Pathol       Date:  1973-11       Impact factor: 7.996

2.  Some observations on the pathology of Swainsona SPP poisoning in farm livestock in Eastern Australia.

Authors:  W J Hartley
Journal:  Acta Neuropathol       Date:  1971       Impact factor: 17.088

3.  Neuronopathy in sheep fed Swainsona luteola and S. galegifolia.

Authors:  L Laws; R B Anson
Journal:  Aust Vet J       Date:  1968-10       Impact factor: 1.281

4.  Reactive neuroaxonal dystrophy in children. Clinical pathological correlation.

Authors:  H Mei Liu
Journal:  Acta Neuropathol       Date:  1978-06-30       Impact factor: 17.088

5.  Effects of several lipidosis-inducing drugs upon the area postrema and adjacent medullary nuclei of adult rats. II. Axonal alternations.

Authors:  W Frisch; R Lüllmann-Rauch
Journal:  Acta Neuropathol       Date:  1981       Impact factor: 17.088

6.  Alterations in neuron morphology in feline mannosidosis. A Golgi study.

Authors:  S U Walkley; W F Blakemore; D P Purpura
Journal:  Acta Neuropathol       Date:  1981       Impact factor: 17.088

7.  Mannosidosis: pathology of the nervous system.

Authors:  J H Sung; M Hayano; R J Desnick
Journal:  J Neuropathol Exp Neurol       Date:  1977 Sep-Oct       Impact factor: 3.685

8.  Experimental poisoning of horses and cattle with Swainsona canescens var horniana.

Authors:  K B Locke; D R McEwan; I J Hamdorf
Journal:  Aust Vet J       Date:  1980-08       Impact factor: 1.281

9.  Meganeurites and other aberrant processes of neurons in feline GM1-gangliosidosis: a Golgi study.

Authors:  D P Purpura; H J Baker
Journal:  Brain Res       Date:  1978-03-17       Impact factor: 3.252

10.  Fine structure of meganeurites and secondary growth processes in feline GM1-gangliosidosis.

Authors:  D P Purpura; G D Pappas; H J Baker
Journal:  Brain Res       Date:  1978-03-17       Impact factor: 3.252

View more
  4 in total

1.  Sphingomyelin lipidosis in a cat: Golgi studies.

Authors:  S U Walkley; H J Baker
Journal:  Acta Neuropathol       Date:  1984       Impact factor: 17.088

2.  Mannoside storage and axonal dystrophy in sensory neurones of swainsonine-treated rats: morphogenesis of lesions.

Authors:  C R Huxtable; P R Dorling
Journal:  Acta Neuropathol       Date:  1985       Impact factor: 17.088

3.  The effects of intracisternal enzyme replacement versus sham treatment on central neuropathology in preclinical canine fucosidosis.

Authors:  Gauthami Sudhamayee Kondagari; Jessica Louise Fletcher; Rachel Cruz; Peter Williamson; John J Hopwood; Rosanne Maree Taylor
Journal:  Orphanet J Rare Dis       Date:  2015-11-04       Impact factor: 4.123

Review 4.  Alpha-Mannosidosis: Therapeutic Strategies.

Authors:  Maria Rachele Ceccarini; Michela Codini; Carmela Conte; Federica Patria; Samuela Cataldi; Matteo Bertelli; Elisabetta Albi; Tommaso Beccari
Journal:  Int J Mol Sci       Date:  2018-05-17       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.